TheEdgeResearch
Home / Stocks / GILD

Gilead Sciences, Inc. (GILD)

NASDAQ Healthcare Drug Manufacturers - General
$124.87 ▲ +0.90%
Market Cap
$155.03B
Sector
Healthcare
Industry
Drug Manufacturers - General
Beta
0.33
52-Wk Range
104.46-157.29
CEO
Daniel O'Day
Country
US
Currency
USD

Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectabl…

Open full interactive analysis & DCF →